Raymond Stevens

Raymond Stevens has a diverse work experience spanning various companies and roles. Raymond currently serves as the Chief Executive Officer of Structure Therapeutics, a position they have held since May 2019. Prior to that, Raymond was an Entrepreneur, Founding Director, and Adjunct Professor at ShanghaiTech University starting from January 2011.

Raymond also worked at Danaher Corporation as a Member of the Board of Directors starting from February 2017. From January 2014 to August 2021, they served as a Professor Emeritus and Founding Director at the Bridge Institute-University of Southern California.

In 2013, Raymond founded RuiYi, Inc. and served as a member of the Board of Directors until April 2019. Raymond also worked as a Professor at The Scripps Research Institute from June 1999 to December 2013.

Raymond's entrepreneurial spirit is evident from their roles as a Founder and Board of Director member of both Receptos (2009-2013) and MemRx (2003-2008). Raymond was also a Founder and member of the Scientific Advisory Board at Syrrx from 1999 to 2003.

Raymond began their career as a Professor at the University of California, Berkeley from July 1991 to June 1999.

Raymond Stevens began their educational journey at the University of Southern Maine, where they earned a Bachelor of Science (B.S.) degree in Chemistry between 1981 and 1985. Following this, they attended the University of Southern California, where they obtained a Doctor of Philosophy (PhD) in Chemistry from 1986 to 1988. Raymond then went on to complete a NIH Postdoctoral Fellowship in Biochemistry and Molecular Biology at Harvard University from 1989 to 1991. There is also an additional mention of him pursuing a second PhD in Chemistry at the University of Southern California, although the specific start and end years are not provided.